The study evaluated thermal dynamics associated with CW-TSCPC and TLT using MicroPulse technology, such as temperature peak, ...
Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal ...
TipRanks on MSN
Iridex announces new study in TVST on glaucoma treatments
Iridex (IRIX) announced a newly published study in Translational Vision Science & Technology, TVST, examining the thermal dynamics of transscleral ...
Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...
ViaLase announced the first patient has been treated in its US-based Investigational Device Exemption (IDE) clinical trial ...
Please provide your email address to receive an email when new articles are posted on . BALTIMORE — Although drugs remain the first-line treatment for most glaucoma patients, many glaucoma specialists ...
"SLT is a widely used first-line laser therapy for glaucoma but relies on a Q-switched Nd:YAG laser, which induces cellular turnover rather than directly bypassing outflow resistance. The FLIGHT ...
A review of selective laser trabeculoplasty in glaucoma management, and when it is appropriate to consider as a treatment option. Neil Minkoff, MD: As we move into different types of therapy, laser ...
Laser trabeculoplasty as initial glaucoma therapy avoids complications caused by medications and filtration surgery, but can require repeat laser later, a glaucoma specialist said. Speaking at ...
Glaucoma is one of the leading causes of permanent blindness in the world, affecting more than two million Americans, and more than one hundred million people worldwide. It is a disease of the optic ...
Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results